This is an amazing and fast growing Q4 4C.
Exceeding performance: Key notes $43.8m annualised run rate which is
+$3.8m over expectations. A massive
$12.3m cash receipts banked 73% up from Q3
Should be no more dilution for shareholders from here onwards as EBITDA and operating cashflow positive
